Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank De Wolf

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2013
Prolonged decrease of CD4+ T lymphocytes in HIV-1-infected patients after radiotherapy for a solid tumorSanjay U C Sankatsing, Mariska M J Hillebregt, Luuk Gras, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2015
Changes in HIV RNA and CD4 cell count after acute HCV infection in chronically HIV-infected individualsLuuk Gras, Frank de Wolf, Colette Smit, et al.
Antiviral Therapy|September 14, 2010
Immune restoration and onset of new AIDS-defining events with combination antiretroviral therapy in HIV type-1-infected immigrants in the NetherlandsAnouk M Kesselring, Luuk Gras, Ferdinand W Wit, et al.
AIDS (London, England)|July 26, 2011
The development of an expert system to predict virological response to HIV therapy as part of an online treatment support toolAndrew D Revell, Dechao Wang, Mark A Boyd, et al.
Sexually Transmitted Diseases|December 20, 2007
Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behaviorHenry J C de Vries, Akke K van der Bij, Johan S A Fennema, et al.
Antiviral Therapy|August 23, 2012
No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemiaMarlous L Grijsen, Rebecca Holman, Luuk Gras, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 7, 2007
CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greaterLuuk Gras, Anouk M Kesselring, James T Griffin, et al.
Plos One|October 2, 2012
Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling studyArd van Sighem, Beatriz Vidondo, Tracy R Glass, et al.
AIDS (London, England)|February 19, 2005
Safety of long-term interruption of successful antiretroviral therapy: the ATHENA cohort studyFerdinand Wnm Wit, Daniel H Blanckenberg, Kees Brinkman, et al.
AIDS (London, England)|April 16, 2009
Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral loadRebecca F Baggaley, Jamie T Griffin, Ruth Chapman, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2013
Prolonged decrease of CD4+ T lymphocytes in HIV-1-infected patients after radiotherapy for a solid tumorSanjay U C Sankatsing, Mariska M J Hillebregt, Luuk Gras, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2015
Changes in HIV RNA and CD4 cell count after acute HCV infection in chronically HIV-infected individualsLuuk Gras, Frank de Wolf, Colette Smit, et al.
Antiviral Therapy|September 14, 2010
Immune restoration and onset of new AIDS-defining events with combination antiretroviral therapy in HIV type-1-infected immigrants in the NetherlandsAnouk M Kesselring, Luuk Gras, Ferdinand W Wit, et al.
AIDS (London, England)|July 26, 2011
The development of an expert system to predict virological response to HIV therapy as part of an online treatment support toolAndrew D Revell, Dechao Wang, Mark A Boyd, et al.
Sexually Transmitted Diseases|December 20, 2007
Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behaviorHenry J C de Vries, Akke K van der Bij, Johan S A Fennema, et al.
Antiviral Therapy|August 23, 2012
No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemiaMarlous L Grijsen, Rebecca Holman, Luuk Gras, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 7, 2007
CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greaterLuuk Gras, Anouk M Kesselring, James T Griffin, et al.
Plos One|October 2, 2012
Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling studyArd van Sighem, Beatriz Vidondo, Tracy R Glass, et al.
AIDS (London, England)|February 19, 2005
Safety of long-term interruption of successful antiretroviral therapy: the ATHENA cohort studyFerdinand Wnm Wit, Daniel H Blanckenberg, Kees Brinkman, et al.
AIDS (London, England)|April 16, 2009
Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral loadRebecca F Baggaley, Jamie T Griffin, Ruth Chapman, et al.
Pageof 11